Analyses of human samples and murine models of alcoholic liver disease (ALD) reveal that the Elk-3 target Abhd10 ameliorates hepatotoxic injury and fibrosis in ALD by downregulating PRDX5 S-palmitoylation. This evidence concerns the gene ELK3 and alcoholic liver diseases.